These horses might look like ordinary horses, but there is something highly unusual about their genomes. They are the first of their species to have their DNA edited using CRISPR–Cas9, a technique ...

A gene called SDR42E1 has been identified as a key player in how our bodies absorb and process vitamin D. Researchers found that disabling this gene in colorectal cancer cells not only crippled their ...

Researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs. LMU researchers have investigated how cationic polymers organize on a molecular level ...

ZURICH (Reuters) - Swiss drugmaker Roche put pressure on U.S. gene decoder Illumina to consider its hostile $5.7 billion bid, saying it sees other alternatives if the takeover fails. "Roche and ...

Roche has once extended its $5.70 billion hostile bid for US gene decoder Illumina, giving no sign that it intends to raise its offer. Roche has once extended its $5.70 billion hostile bid for US gene ...

ZURICH (Reuters) - - Swiss drugmaker Roche wrote to Illumina investors directly on Tuesday and urged them to accept its $5.7 billion bid, arguing that the U.S. gene decoder faces pressure on revenue ...